A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

BACKGROUND: Onchocerciasis (“river blindness”) has been targeted for elimination. New treatments that kill or permanently sterilize female worms could accelerate this process. Prior studies have shown that triple drug treatment with ivermectin plus diethylcarbamazine and albendazole (IDA) leads to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Opoku, Nicholas O., Doe, Felix, Dubben, Bettina, Fetcho, Nicole, Fischer, Kerstin, Fischer, Peter U., Gordor, Shelter, Goss, Charles W., Gyasi, Michael E., Hoerauf, Achim, Hong, Augustine R., Kanza, Eric, King, Christopher L., Laryea, Ruth, Lew, Daphne, Seidu, Mahmood A., Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234528/
https://www.ncbi.nlm.nih.gov/pubmed/37205721
http://dx.doi.org/10.1371/journal.pntd.0011365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234528/
https://www.ncbi.nlm.nih.gov/pubmed/37205721
http://dx.doi.org/10.1371/journal.pntd.0011365

Ejemplares similares